. Author manuscript; available in PMC: 2012 Jun 15.

Published in final edited form as: Eur J Nucl Med Mol Imaging. 2011 May 11;38(9):1595–1606. doi: 10.1007/s00259-011-1834-9

Table IV.

ROC analysis results with area under the curve (AUC) and associated 95% confidence intervals (CI), specificity (sp) and sensitivity (se) for each parameter regarding the two classification tasks.

Parameter		ROC analysis
		NR&PR(n=38) vs. CR(n=12)				NR(n=13) vs. PR&CR(n=37)
		AUC	95%CI	Se(%)	Sp(%)	AUC	95%CI	Se(%)	Sp(%)
Age		0.51	[0.32–0.70]	83.3	31.6	0.55	[0.35–0.75]	86.5	36.5
Gender		0.61	[0.46–0.75]	27.3	94.3	0.51	[0.41–0.62]	90.9	11.4
T		0.70	[0.47–0.93]	60.0	89.3	0.64	[0.49–0.78]	100.0	33.3
N		0.64	[0.46–0.83]	60.0	68.8	0.55	[0.38–0.73]	70.0	40.6
M		0.56	[0.38–0.73]	70.0	41.2	0.70	[0.53–0.87]	70.0	70.6
AJCC stage		0.63	[0.43–0.84]	54.6	73.5	0.72	[0.57–0.88]	87.5	46.2
Histology type		0.51	[0.35–0.66]	72.7	28.2	0.60	[0.46–0.75]	42.9	77.8
SUV_max		0.65	[0.45–0.85]	33.3	94.7	0.54	[0.34–0.73]	30.8	89.2
SUV_peak		0.69	[0.49–0.89]	75.0	63.2	0.54	[0.35–0.73]	30.8	86.5
SUV_mean	T_A1	0.67	[0.47–0.87]	50.0	84.2	0.54	[0.35–0.74]	89.2	38.0
	T_A2	0.67	[0.45–0.88]	50.0	94.7	0.51	[0.32–0.70]	100.0	16.2
	FLAB	0.65	[0.43–0.87]	58.3	84.2	0.51	[0.32–0.70]	100.0	13.5
TL	T_A1	0.81	[0.65–0.97]	83.3	79.0	0.78	[0.63–0.93]	59.5	92.3
	T_A2	0.79	[0.63–0.96]	83.3	73.3	0.75	[0.61–0.90]	75.7	69.2
	FLAB	0.79	[0.64–0.94]	83.3	65.8	0.82	[0.70–0.94]	59.5	92.3
TV	T_A1	0.79	[0.65–0.89]	75.0	81.6	0.79	[0.65–0.93]	78.4	69.2
	T_A2	0.74	[0.59–0.85]	83.3	57.9	0.81	[0.67–0.95]	94.6	53.9
	FLAB	0.78	[0.64–0.88]	75.0	79.0	0.84	[0.72–0.96]	75.7	76.9
TLG	T_A1	0.81	[0.62–1.00]	66.7	92.1	0.78	[0.65–0.92]	92.3	56.8
	T_A2	0.80	[0.61–0.99]	75.0	86.8	0.80	[0.67–0.93]	69.2	81.1
	FLAB	0.85	[0.73–0.98]	75.0	92.1	0.86	[0.75–0.98]	84.6	75.7